ContactUsLinkComponent

Monoclonal antibodies (mAbs)

Optimize your mAbs bioprocessing performance with industry-leading solutions

Monoclonal antibodies (mAbs) are at the forefront of the biological products market. They will continue to lead resource investment in the biopharmaceutical industry to help provide innovative therapeutic solutions for immune-oncology and immunotherapy.

Avantor® offers an industry-leading portfolio of upstream, downstream, and drug product bioprocessing solutions. Our solutions help you maintain mAbs quality, activity, and stability throughout the entire process.

AVT-DG-003-mAbScaleUp-BNR-FNL (1).png

How can we help?

Avantor’s solutions, combined with our experience and insights into bioprocessing optimization, can help biopharma manufacturers increase mAb titers, mAb fragments that can be manufactured in other expression systems, multiple target specificity for mAbs, and the development of Antibody-Drug Conjugates (ADCs) that deliver drugs to targeted cancer cells.

Our portfolio includes mission-critical products and services that support every stage of your process, from monoclonal antibodies research to production. We have a global infrastructure that serves more than 225,000 customer locations worldwide. Let us improve your bioproduction efficiencies so you can focus on scientific breakthroughs.

hydration-solutions-1074985262-260x190.jpg

Avantor's hydration solutions

Avantor is the ideal partner to develop innovative, customized, buffer solutions that save you time, resources, and money.

Play video

Explore our mAbs manufacturing products

To find a channel partner in your region, please click here.

More resources

Related content

Ready to move forward? Contact us to get started.